Format

Send to

Choose Destination
Angew Chem Int Ed Engl. 2018 Oct 22;57(43):14080-14084. doi: 10.1002/anie.201807970. Epub 2018 Oct 3.

Genome Editing Reveals Novel Thiotemplated Assembly of Polythioamide Antibiotics in Anaerobic Bacteria.

Author information

1
Dept. of Biomolecular Chemistry, Leibniz Institute for Natural Product Research and Infection Biology, HKI, Beutenbergstrasse 11a, 07745, Jena, Germany.
2
Natural Product Chemistry, Friedrich Schiller University, 07743, Jena, Germany.

Abstract

Closthioamide (CTA) is a unique symmetric nonribosomal peptide with six thioamide moieties that is produced by the Gram-positive obligate anaerobe Ruminiclostridium cellulolyticum. CTA displays potent inhibitory activity against important clinical pathogens, making it a promising drug candidate. Yet, the biosynthesis of this DNA gyrase-targeting antibiotic has remained enigmatic. Using a combination of genome mining, genome editing (targeted group II intron, CRISPR/Cas9), and heterologous expression, we show that CTA biosynthesis involves specialized enzymes for starter unit biosynthesis, amide bond formation, thionation, and dimerization. Surprisingly, CTA biosynthesis involves a novel thiotemplated peptide assembly line that markedly differs from known nonribosomal peptide synthetases. These findings provide the first insights into the biosynthesis of thioamide-containing nonribosomal peptides and offer a starting point for the discovery of related natural products.

KEYWORDS:

biosynthesis; clostridia; natural products; thioamides; thiotemplate systems

PMID:
30193003
DOI:
10.1002/anie.201807970

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center